CoChat

High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor‐infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma

Park, Min Ho, Lee, Ji Shin, Yoon, Jung Han · 2012 · Journal of Surgical Oncology
Cited by 121

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background: CX3CL1 is the only CX3C chemokine that can chemoattract T cells, natural killer (NK) cells, and dendritic cells (DCs). The role of CX3CL1 in breast carcinoma remains unknown. Methods: Immunohistochemical staining for CX3CL1, CD8, CD57, and CD1a was performed on 204 breast carcinoma specimens using tissue microarray blocks to determine whether CX3CL1 expression correlated with a good prognosis and antitumor immunity. Results: The number of stromal CD8+ T cells, intratumoral CD1a+ DCs, and stromal CD57+ NK cells were significantly increased in the high CX3CL1 expression group compared with those in the low CX3CL1expression group. Patients with high CX3CL1 expression had a significantly better disease‐free and overall survival than those with low CX3CL1 expression (P = 0.002 and P < 0.001, respectively). CX3CL1 expression was identified as one of the independent prognostic factors for disease‐free and overall survival (P = 0.046 and P = 0.010, respectively). Conclusion: The expression of CX3CL1 by tumor cells appears to enhance the recruitment of CD8+ T cells, CD57+ NK cells, and CD1a+ DCs, thereby bringing about a better prognosis in breast carcinoma. CX3CL1 is a new prognostic biomarker and may be a novel candidate for development of a more effective therapeutic strategy for breast carcinoma. J. Surg. Oncol. 2012; 106:386–392. © 2012 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jso.23095

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 28

  1. 10.3346/jkms.2010.25.8.1113 · DOI · Paper page
  2. 10.3816/CBC.2003.s.018 · doi:10.3816/cbc.2003.s.018
  3. 10.1089/gtmb.2009.0060 · DOI
  4. 10.1517/14656566.9.15.2639 · DOI
  5. Wei S, 2005, Novel tumor immunotherapy: Targeting dysfunctional antigen presenting cells, Discov Med, 5, 489
  6. 10.1038/sj.bjc.6690780 · doi:10.1038/sj.bjc.6690780
  7. 10.1038/nrc928 · DOI · Paper page
  8. 10.1016/S0140-6736(05)17717-4 · DOI
  9. 10.1016/j.imlet.2004.05.006 · DOI
  10. 10.1016/S1074-7613(00)80165-X · DOI · Paper page
  11. 10.1016/S0076-6879(09)05201-X · doi:10.1016/s0076-6879(09)05201-x
  12. 10.1016/S0092-8674(00)80438-9 · DOI · Paper page
  13. 10.1002/ijc.10816 · DOI · Paper page
  14. Lavergne E, 2003, Fractalkine mediates natural killer‐dependent antitumor responses in vivo, Cancer Res, 63, 7468
  15. 10.1002/eji.200526042 · DOI · Paper page
  16. 10.1002/eji.200535549 · DOI · Paper page
  17. Ohta M, 2005, The high expression of Fractalkine results in a better prognosis for colorectal cancer patients, Int J Oncol, 26, 41
  18. 10.1245/s10434-008-9876-3 · DOI
  19. 10.1002/jso.20642 · DOI · Paper page
  20. 10.1038/labinvest.3700055 · DOI · Paper page
  21. 10.1111/j.1365-2559.2007.02919.x · DOI
  22. 10.1111/j.1365-2559.2009.03379.x · DOI
  23. 10.1371/journal.pone.0018219 · DOI · Paper page
  24. 10.1200/JCO.2010.30.5037 · DOI · Paper page
  25. 10.1016/S0960-9776(03)00004-3 · doi:10.1016/s0960-9776(03)00004-3
  26. Matkowski R, 2009, The prognostic role of tumor‐infiltrating CD4 and CD8 T lymphocytes in breast cancer, Anticancer Res, 29, 2445
  27. 10.1093/annonc/mdl053 · DOI · Paper page
  28. 10.1002/jnr.10304 · DOI · Paper page

Cited by

See all 121

Metadata

Authors
Park, M. H., Lee, J. S., & Yoon, J. H.
Venue
Journal of Surgical Oncology
Publisher
Wiley
Published
2012-03-15
Volume
106
Issue
4
Pages
386-392
ISSN
  • 0022-4790 (ISSN-L)
  • 1096-9098
OpenAlex
W2120687087
Cited by
121
References
1
FWCI
3.12
Type
journal article
Language
en
Open access
closed
Funders
  • Research Institute of Medical Sciences, Chonnam National University (2010-CURIMS-DR010)
  • Ministry of Education, Science and Technology (2011-0030034)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor‐infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. https://app.cochat.ai/papers/10.1002/jso.23095
The paper
Park, M. H., Lee, J. S., & Yoon, J. H. (2012). High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor‐infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. Journal of Surgical Oncology. https://doi.org/10.1002/jso.23095

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.